Evaluation of microbial flora in eyes with a Boston type 1 Keratoprosthesis

Cornea

Volumn 32, Issue 12, 2013, Pages 1537-1539

  Lee, Samuel H ^a   Mannis, Mark J ^a   Shapiro, Brett ^a   Li, Jennifer Y ^a   Polage, Christopher ^b   Smith, Wayne ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

infectious endophthalmitis; K Pro; K Pro culture; keratoprosthesis; keratoprosthesis culture; sonication

Indexed keywords

BALANCED SALT SOLUTION; GATIFLOXACIN; MOXIFLOXACIN; POLYMYXIN; POLYTRIM; THIOGLYCOLIC ACID; TRIMETHOPRIM; VANCOMYCIN;

ARTICLE; BACTERIAL GROWTH; BANDAGE CONTACT LENS; BOSTON TYPE 1 KERATOPROSTHESIS; CHEMICAL BURN; CLINICAL ARTICLE; CONJUNCTIVA; CONTACT LENS; CONTROLLED STUDY; CORNEA TRANSPLANTATION; ENDOPHTHALMITIS; EVALUATION; EYE; GRAFT FAILURE; HUMAN; IMPLANTATION; KERATOPROSTHESIS; LIQUID; MICROFLORA; OPTICAL INSTRUMENTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEM CELL; STEVENS JOHNSON SYNDROME;

ADULT; ANTI-BACTERIAL AGENTS; ARTIFICIAL ORGANS; CONJUNCTIVA; CORNEA; CORNEAL DISEASES; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS;

EID: 84888131364     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182a81992     Document Type: Article

References (11)

1. Doane MG, Dohlman CH, Bearse G. Fabrication of a keratoprosthesis. Cornea. 1996;15:179-184.
2. Dohlman CH, Dudenhoefer EJ, Khan BF, et al. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28:72-74.
3. Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28:896-901.
4. Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012;96: 776-780.
5. Ramchandran RS, Diloreto DA Jr, Chung MM, et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology. 2012;119:674-681.
6. Sherertz RJ, Raad II, Belani A, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol. 1990;28:76-82.
7. Slobbe L, El Barzouhi A, Boersma E, et al. Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective study. J Clin Microbiol. 2009;47:885-888.
8. Magalhães FP, do Nascimento HM, Ecker DJ, et al. Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine. Cornea. 2013; 32: 407-411.
9. Kim SJ, Toma HS. Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch Ophthalmol. 2011;129:1180-1188.
10. Chan KP, Chu KO, Lai WW, et al. Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection. Anal Biochem. 2006;353:30-36.
11. Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119:484-489.